Industry Research Reports
Home > Reports > Service & Software > Global Molecular Methods Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Molecular Methods Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-10-25
Pages: 141 Pages
Report ld: 5253029
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Molecular Methods market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Instrument accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Molecular Methods leading manufacturers including QIAGEN, 3M, Veredus Laboratories, Neogen Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, bioMérieux, ArcherDX, HiMedia Laboratories, Eurofins Scientific, etc., dominate supply; the top five capture approximately % of global revenue, with QIAGEN leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Molecular Methods market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- QIAGEN
- 3M
- Veredus Laboratories
- Neogen Corporation
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- bioMérieux
- ArcherDX
- HiMedia Laboratories
- Eurofins Scientific
- SGS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Polymerase Chain Reaction (PCR)
- Immunoassay
- Biosensors
- Microarray
- Other
Segment by Application
- Instrument
- Reagents & Consumables
- Services
CHAPTER OUTLINE
Chapter 1: Defines the Molecular Methods study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Molecular Methods: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Molecular Methods Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunoassay
1.2.4 Biosensors
1.2.5 Microarray
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Molecular Methods Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Instrument
1.3.3 Reagents & Consumables
1.3.4 Services
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Molecular Methods Revenue Estimates and Forecasts 2020-2031
2.2 Global Molecular Methods Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Molecular Methods Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Molecular Methods Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Polymerase Chain Reaction (PCR) Market Size by Players
3.3.2 Immunoassay Market Size by Players
3.3.3 Biosensors Market Size by Players
3.3.4 Microarray Market Size by Players
3.3.5 Other Market Size by Players
3.4 Global Molecular Methods Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Molecular Methods Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Molecular Methods Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Molecular Methods Market Size by Type (2020-2031)
6.4 North America Molecular Methods Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Molecular Methods Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Molecular Methods Market Size by Type (2020-2031)
7.4 Europe Molecular Methods Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Molecular Methods Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Molecular Methods Market Size by Type (2020-2031)
8.4 Asia-Pacific Molecular Methods Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Molecular Methods Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Molecular Methods Market Size by Type (2020-2031)
9.4 Central and South America Molecular Methods Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Molecular Methods Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Molecular Methods Market Size by Type (2020-2031)
10.4 Middle East and Africa Molecular Methods Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Molecular Methods Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 QIAGEN
11.1.1 QIAGEN Corporation Information
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Molecular Methods Product Features and Attributes
11.1.4 QIAGEN Molecular Methods Revenue and Gross Margin (2020-2025)
11.1.5 QIAGEN Molecular Methods Revenue by Product in 2024
11.1.6 QIAGEN Molecular Methods Revenue by Application in 2024
11.1.7 QIAGEN Molecular Methods Revenue by Geographic Area in 2024
11.1.8 QIAGEN Molecular Methods SWOT Analysis
11.1.9 QIAGEN Recent Developments
11.2 3M
11.2.1 3M Corporation Information
11.2.2 3M Business Overview
11.2.3 3M Molecular Methods Product Features and Attributes
11.2.4 3M Molecular Methods Revenue and Gross Margin (2020-2025)
11.2.5 3M Molecular Methods Revenue by Product in 2024
11.2.6 3M Molecular Methods Revenue by Application in 2024
11.2.7 3M Molecular Methods Revenue by Geographic Area in 2024
11.2.8 3M Molecular Methods SWOT Analysis
11.2.9 3M Recent Developments
11.3 Veredus Laboratories
11.3.1 Veredus Laboratories Corporation Information
11.3.2 Veredus Laboratories Business Overview
11.3.3 Veredus Laboratories Molecular Methods Product Features and Attributes
11.3.4 Veredus Laboratories Molecular Methods Revenue and Gross Margin (2020-2025)
11.3.5 Veredus Laboratories Molecular Methods Revenue by Product in 2024
11.3.6 Veredus Laboratories Molecular Methods Revenue by Application in 2024
11.3.7 Veredus Laboratories Molecular Methods Revenue by Geographic Area in 2024
11.3.8 Veredus Laboratories Molecular Methods SWOT Analysis
11.3.9 Veredus Laboratories Recent Developments
11.4 Neogen Corporation
11.4.1 Neogen Corporation Corporation Information
11.4.2 Neogen Corporation Business Overview
11.4.3 Neogen Corporation Molecular Methods Product Features and Attributes
11.4.4 Neogen Corporation Molecular Methods Revenue and Gross Margin (2020-2025)
11.4.5 Neogen Corporation Molecular Methods Revenue by Product in 2024
11.4.6 Neogen Corporation Molecular Methods Revenue by Application in 2024
11.4.7 Neogen Corporation Molecular Methods Revenue by Geographic Area in 2024
11.4.8 Neogen Corporation Molecular Methods SWOT Analysis
11.4.9 Neogen Corporation Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Molecular Methods Product Features and Attributes
11.5.4 Thermo Fisher Scientific Molecular Methods Revenue and Gross Margin (2020-2025)
11.5.5 Thermo Fisher Scientific Molecular Methods Revenue by Product in 2024
11.5.6 Thermo Fisher Scientific Molecular Methods Revenue by Application in 2024
11.5.7 Thermo Fisher Scientific Molecular Methods Revenue by Geographic Area in 2024
11.5.8 Thermo Fisher Scientific Molecular Methods SWOT Analysis
11.5.9 Thermo Fisher Scientific Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Corporation Information
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Molecular Methods Product Features and Attributes
11.6.4 Bio-Rad Laboratories Molecular Methods Revenue and Gross Margin (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 bioMérieux
11.7.1 bioMérieux Corporation Information
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux Molecular Methods Product Features and Attributes
11.7.4 bioMérieux Molecular Methods Revenue and Gross Margin (2020-2025)
11.7.5 bioMérieux Recent Developments
11.8 ArcherDX
11.8.1 ArcherDX Corporation Information
11.8.2 ArcherDX Business Overview
11.8.3 ArcherDX Molecular Methods Product Features and Attributes
11.8.4 ArcherDX Molecular Methods Revenue and Gross Margin (2020-2025)
11.8.5 ArcherDX Recent Developments
11.9 HiMedia Laboratories
11.9.1 HiMedia Laboratories Corporation Information
11.9.2 HiMedia Laboratories Business Overview
11.9.3 HiMedia Laboratories Molecular Methods Product Features and Attributes
11.9.4 HiMedia Laboratories Molecular Methods Revenue and Gross Margin (2020-2025)
11.9.5 HiMedia Laboratories Recent Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Corporation Information
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Molecular Methods Product Features and Attributes
11.10.4 Eurofins Scientific Molecular Methods Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 SGS
11.11.1 SGS Corporation Information
11.11.2 SGS Business Overview
11.11.3 SGS Molecular Methods Product Features and Attributes
11.11.4 SGS Molecular Methods Revenue and Gross Margin (2020-2025)
11.11.5 SGS Recent Developments
12 Molecular MethodsIndustry Chain Analysis
12.1 Molecular Methods Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Molecular Methods Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Molecular Methods Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Molecular Methods Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Molecular Methods Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Molecular Methods Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Molecular Methods Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Molecular Methods Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Molecular Methods Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Molecular Methods Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Molecular Methods by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Methods as of 2024)
Table 11. Global Molecular Methods Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Molecular Methods Companies Headquarters
Table 13. Global Molecular Methods Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Molecular Methods Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Molecular Methods Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Molecular Methods Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Molecular Methods Revenue by Application (2026-2031) & (US$ Million)
Table 21. Molecular Methods High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Molecular Methods Growth Accelerators and Market Barriers
Table 25. North America Molecular Methods Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Molecular Methods Growth Accelerators and Market Barriers
Table 27. Europe Molecular Methods Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Molecular Methods Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Molecular Methods Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Molecular Methods Investment Opportunities and Key Challenges
Table 31. Central and South America Molecular Methods Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Molecular Methods Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Molecular Methods Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. QIAGEN Corporation Information
Table 35. QIAGEN Description and Major Businesses
Table 36. QIAGEN Product Features and Attributes
Table 37. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. QIAGEN Revenue Proportion by Product in 2024
Table 39. QIAGEN Revenue Proportion by Application in 2024
Table 40. QIAGEN Revenue Proportion by Geographic Area in 2024
Table 41. QIAGEN Molecular Methods SWOT Analysis
Table 42. QIAGEN Recent Developments
Table 43. 3M Corporation Information
Table 44. 3M Description and Major Businesses
Table 45. 3M Product Features and Attributes
Table 46. 3M Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. 3M Revenue Proportion by Product in 2024
Table 48. 3M Revenue Proportion by Application in 2024
Table 49. 3M Revenue Proportion by Geographic Area in 2024
Table 50. 3M Molecular Methods SWOT Analysis
Table 51. 3M Recent Developments
Table 52. Veredus Laboratories Corporation Information
Table 53. Veredus Laboratories Description and Major Businesses
Table 54. Veredus Laboratories Product Features and Attributes
Table 55. Veredus Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Veredus Laboratories Revenue Proportion by Product in 2024
Table 57. Veredus Laboratories Revenue Proportion by Application in 2024
Table 58. Veredus Laboratories Revenue Proportion by Geographic Area in 2024
Table 59. Veredus Laboratories Molecular Methods SWOT Analysis
Table 60. Veredus Laboratories Recent Developments
Table 61. Neogen Corporation Corporation Information
Table 62. Neogen Corporation Description and Major Businesses
Table 63. Neogen Corporation Product Features and Attributes
Table 64. Neogen Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Neogen Corporation Revenue Proportion by Product in 2024
Table 66. Neogen Corporation Revenue Proportion by Application in 2024
Table 67. Neogen Corporation Revenue Proportion by Geographic Area in 2024
Table 68. Neogen Corporation Molecular Methods SWOT Analysis
Table 69. Neogen Corporation Recent Developments
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Major Businesses
Table 72. Thermo Fisher Scientific Product Features and Attributes
Table 73. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 75. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 76. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 77. Thermo Fisher Scientific Molecular Methods SWOT Analysis
Table 78. Thermo Fisher Scientific Recent Developments
Table 79. Bio-Rad Laboratories Corporation Information
Table 80. Bio-Rad Laboratories Description and Major Businesses
Table 81. Bio-Rad Laboratories Product Features and Attributes
Table 82. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Bio-Rad Laboratories Recent Developments
Table 84. bioMérieux Corporation Information
Table 85. bioMérieux Description and Major Businesses
Table 86. bioMérieux Product Features and Attributes
Table 87. bioMérieux Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. bioMérieux Recent Developments
Table 89. ArcherDX Corporation Information
Table 90. ArcherDX Description and Major Businesses
Table 91. ArcherDX Product Features and Attributes
Table 92. ArcherDX Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. ArcherDX Recent Developments
Table 94. HiMedia Laboratories Corporation Information
Table 95. HiMedia Laboratories Description and Major Businesses
Table 96. HiMedia Laboratories Product Features and Attributes
Table 97. HiMedia Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. HiMedia Laboratories Recent Developments
Table 99. Eurofins Scientific Corporation Information
Table 100. Eurofins Scientific Description and Major Businesses
Table 101. Eurofins Scientific Product Features and Attributes
Table 102. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Eurofins Scientific Recent Developments
Table 104. SGS Corporation Information
Table 105. SGS Description and Major Businesses
Table 106. SGS Product Features and Attributes
Table 107. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. SGS Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Methods Product Picture
Figure 2. Global Molecular Methods Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Polymerase Chain Reaction (PCR) Product Picture
Figure 4. Immunoassay Product Picture
Figure 5. Biosensors Product Picture
Figure 6. Microarray Product Picture
Figure 7. Other Product Picture
Figure 8. Global Molecular Methods Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Instrument
Figure 10. Reagents & Consumables
Figure 11. Services
Figure 12. Molecular Methods Report Years Considered
Figure 13. Global Molecular Methods Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 15. Global Molecular Methods Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Molecular Methods Revenue Market Share by Region (2020-2031)
Figure 17. Global Molecular Methods Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Polymerase Chain Reaction (PCR) Revenue Market Share by Player in 2024
Figure 20. Immunoassay Revenue Market Share by Player in 2024
Figure 21. Biosensors Revenue Market Share by Player in 2024
Figure 22. Microarray Revenue Market Share by Player in 2024
Figure 23. Other Revenue Market Share by Player in 2024
Figure 24. Global Molecular Methods Revenue Market Share by Type (2020-2031)
Figure 25. Global Molecular Methods Revenue Market Share by Application (2020-2031)
Figure 26. North America Molecular Methods Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Molecular Methods Revenue (US$ Million) in 2024
Figure 28. North America Molecular Methods Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Molecular Methods Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Molecular Methods Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Molecular Methods Revenue (US$ Million) in 2024
Figure 35. Europe Molecular Methods Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Molecular Methods Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 38. France Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Molecular Methods Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Molecular Methods Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Molecular Methods Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Molecular Methods Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 50. India Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Molecular Methods Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Molecular Methods Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Molecular Methods Revenue (US$ Million) in 2024
Figure 58. Central and South America Molecular Methods Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Molecular Methods Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Molecular Methods Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Molecular Methods Revenue (US$ Million) in 2024
Figure 64. South America Molecular Methods Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Molecular Methods Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Molecular Methods Revenue (2020-2025) & (US$ Million)
Figure 70. Molecular Methods Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Molecular Methods market?
The top companies in the global Molecular Methods market are QIAGEN、3M、Veredus Laboratories.
Related Reports
Molecular Methods - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Methods was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 115
USD 3950.00
(Single User License)
Global Molecular Methods Market Research Report 2026
The global Molecular Methods market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 112
USD 2900.00
(Single User License)
Global Molecular Methods Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Molecular Methods market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 95
USD 4250.00
(Single User License)
Molecular Methods- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Molecular Methods was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 103
USD 3950.00
(Single User License)
Global Molecular Methods Market Research Report 2025
The global market for Molecular Methods was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 85
USD 2900.00
(Single User License)
Global Molecular Methods Market Insights, Forecast to 2030
Market Analysis and Insights: Global Molecular Methods Market
Published Date: 2024-04-06
Pages: 107
USD 4900.00
(Single User License)
Global Molecular Methods Market Research Report 2024
The global Molecular Methods market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 84
USD 2900.00
(Single User License)
Molecular Methods - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Methods was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 115
USD 3950.00 (Single User License)Global Molecular Methods Market Research Report 2026
The global Molecular Methods market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 112
USD 2900.00 (Single User License)Global Molecular Methods Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Molecular Methods market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 95
USD 4250.00 (Single User License)Molecular Methods- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Molecular Methods was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 103
USD 3950.00 (Single User License)Global Molecular Methods Market Research Report 2025
The global market for Molecular Methods was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 85
USD 2900.00 (Single User License)Global Molecular Methods Market Insights, Forecast to 2030
Market Analysis and Insights: Global Molecular Methods Market
Published: 2024-04-06
Pages: 107
USD 4900.00 (Single User License)Global Molecular Methods Market Research Report 2024
The global Molecular Methods market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now